MedPath

Study of Surgically-Induced Weight Loss on Pelvic Floor Disorders

Completed
Conditions
Pelvic Floor Disorders
Interventions
Procedure: LapBand
Registration Number
NCT00884871
Lead Sponsor
University of California, San Diego
Brief Summary

The specific aim of this study is to evaluate the effect of surgically-induced weight reduction, as achieved by laparoscopic gastric banding or sleeve gastrectomy, on pelvic floor disorders such as stress urinary incontinence, overactive bladder, anal incontinence, and pelvic organ prolapse in severely, morbidly and super-obese women using a prospective, observational study design.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
100
Inclusion Criteria
  • surgical eligibility met by Center for the Treatment Obesity criteria
  • morbid obesity (BMI > 40 kg/m2) or severe obesity (BMI > 33 kg/m2) in presence of NIH co-morbidities
  • willing to participate in study, including completion of self-reported questionnaires
Exclusion Criteria
  • pregnancy or planned pregnancy
  • recent pregnancy or pelvic surgery
  • age < 21 years
  • known neurologic disease or pelvic pathology

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Laparoscopic adjustable gastric bandingLapBand100 obese women undergoing laparoscopic adjustable gastric banding
Primary Outcome Measures
NameTimeMethod
Prevalence of pelvic floor disorders ascertained by Epidemiology of Prolapse and Incontinence Questionnaire12 months
Secondary Outcome Measures
NameTimeMethod
Weekly incontinence episodes and pad use ascertained by incontinence diary12 months
Quality of life impact ascertained by validated measures (PFIQ, PFDI, FISI, and PGI-I)12 months
Sexual function ascertained by validated measure (PISQ)12 months

Trial Locations

Locations (1)

University of California San Diego Medical Center

🇺🇸

La Jolla, California, United States

© Copyright 2025. All Rights Reserved by MedPath